Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xiaozhe Li
1q21 Gain Combined With High‐Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China
Oncologist
Cancer Research
Medicine
Oncology
Related publications
Concomitant Gain of 1q21 and MYC Translocation Define a Poor Prognostic Subgroup of Hyperdiploid Multiple Myeloma
Haematologica
Hematology
Quantification of Clonal Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: Implications for Redefining High-Risk Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Daratumumab in Untreated Newly Diagnosed Multiple Myeloma
Therapeutic Advances in Hematology
Hematology
Prognostic Nomogram for the Overall Survival of Patients With Newly Diagnosed Multiple Myeloma
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CHAMPION-2)
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Bortezomib Overcomes the Negative Prognostic Impact of Renal Impairment in a Newly Diagnosed Elderly Patient With Multiple Myeloma: A Case Report
Oncology Letters
Cancer Research
Oncology
FOXM1 Is a Therapeutic Target in High-Risk Multiple Myeloma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Increasing Newly Diagnosed Rate and Changing Risk Factors of HCV in Yanbian Prefecture, a High Endemic Area in China
PLoS ONE
Multidisciplinary
Time to Plateau as a Predictor of Survival in Newly Diagnosed Multiple Myeloma
American Journal of Hematology
Hematology
